METHODS

Design:

randomised controlled trial.

Allocation:

{concealed*}.

Blinding:

blinded (data collectors}.*

Follow up period:

1 year.

Setting:

6 sites in the UK.

Patients:

422 patients {18–65 years of age}‡ {mean age 40 y, 77% men}‡ who had an ICD-10 diagnosis of schizophrenia and were receiving treatment from psychiatry secondary sources. Patients were excluded if they were in the process of active relapse or had a primary diagnosis of substance or alcohol dependence, organic brain disease, or severe learning disability.

Intervention:

CBT {n = 257}‡ or usual care as organised by a community key worker, with an offer of CBT at the end of the study period {n = 165} …